Impression Healthcare secures long term oil supply agreement, unveils new cannabis discovery brand Incannex

Impression Healthcare ASX IHL Incannex Pharmaceuticals medicinal cannabis oil supply cannabinoid
Impression Healthcare has established Incannex Pharmaceuticals to develop and sell novel cannabinoid formulations.

Impression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after unveiling the all-new cannabinoid drug discovery brand Incannex Pharmaceuticals.

As a new entity, Incannex will engage Linnea SA, an EU-based, global leader in custom cannabinoid drug design to be their supply partner over the next five years.

The European company will provide the base cannabinoid materials for the four cannabinoid formulations being designed by Incannex.

According to Impression, the areas of research that will receive prime focus will be obstructive sleep apnoea,

... read more at: https://smallcaps.com.au/impression-healthcare-oil-supply-agreement-linnea-cannabis-brand-incannex/

by

Leave a Reply